Schedule 13G ownership disclosure

REXAHN PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 761640101

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,500,000
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-000216
Form type
SC 13G/A
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 17, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub